Non Animal Testing Database
EnglischDeutsch
Download XML for Micrsoft Excel
Download CSV for Microsoft Excel
Copy search query
Print / PDF

Cancer patients at greater risk from COVID-19 but some therapies can help

2020
Università della Svizzera Italiana, Bellinzona, Switzerland
#androgen-deprivation, #cancer, #coronavirus, #COVID-19, #prostate cancer, #SARS-CoV-2
This epidemiologic study analysed 9280 SARS-Cov-2-positive patients from Italy and shows that cancer patients have an increased risk of SARS-CoV-2 infections than non-cancer patients. However, prostate cancer patients receiving androgen-deprivation therapies appear to be partially protected from SARS-CoV-2 infections.
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
Andrea Alimonti

M. Montopoli et al. Annals of Oncology 2020 [1]   URL
#122
Added on: 05-25-2020
[1] https://www.annalsofoncology.org/article/S0923-7534(20)39797-0/fulltext
Back to Top
English German
Project of


Supported by


Logo
Lush Prize Winner 2022


Lush Prize Winner 2022
Winner of the Animal Protection Prize of Lower Saxony 2022

Winner of the Animal Protection Prize of Lower Saxony 2022

Suscribe to RSS Feed Legal Notice Privacy Policy

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!